首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)-A NEW CARDIOVASCULAR RISK FACTOR IN PERITONEAL DIALYSIS PATIENTS
【24h】

NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)-A NEW CARDIOVASCULAR RISK FACTOR IN PERITONEAL DIALYSIS PATIENTS

机译:壬酸脂肪肝疾病(NAFLD)-腹膜透析患者的一种新的心血管危险因素

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Recent investigations indicated that nonalcoholic fatty liver disease (NAFLD), a hepatic component of metabolic syndrome (MS), is associated with an increased risk of cardiovascular disease (CVD). Accordingly, we were interested in exploring the frequency of NAFLD in peritoneal dialysis (PD) patients and analyzing factors in PD patients associated with NAFLD occurrence. In addition, we were interested in investigating whether NAFLD is associated with higher CVD risk in our PD patients.
机译:背景:最近的研究表明,非酒精性脂肪肝疾病(NAFLD)是代谢综合征(MS)的肝脏成分,与心血管疾病(CVD)的风险增加有关。因此,我们有兴趣探讨腹膜透析(PD)患者中NAFLD的发生频率,并分析与NAFLD发生有关的PD患者中的因素。此外,我们对研究NAFLD是否与PD患者的较高CVD风险相关感兴趣。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号